Evaluation of the tolerability and immunogenicity of ultraviolet C-irradiated autologous platelets in a dog model

Transfusion

Volumn 52, Issue 11, 2012, Pages 2414-2426

  Pohler, Petra ^a   Lehmann, Jörg ^a   Veneruso, Verena ^a   Tomm, Janina ^a   Von Bergen, Martin ^a   Lambrecht, Bernd ^a   Kohn, Barbara ^a   Weingart, Christiane ^a   Müller, Thomas H ^a   Seltsam, Axel ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; PLASMA PROTEIN; PROTEOME; THROMBOCYTE CONCENTRATE;

ANTIBODY RESPONSE; ARTICLE; BLOOD; CANINE ADENOVIRUS; CONTROLLED STUDY; DOG; DRUG TOLERANCE; EVALUATION; FLOW CYTOMETRY; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; MALE; NONHUMAN; PROTEIN MODIFICATION; PROTEOMICS; SPECTRAL SENSITIVITY; THROMBOCYTE; TWO DIMENSIONAL GEL ELECTROPHORESIS; ULTRAVIOLET C RADIATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; BLOOD PLATELETS; BLOOD PROTEINS; BLOOD SAFETY; BLOOD TRANSFUSION, AUTOLOGOUS; DOGS; FLOW CYTOMETRY; IMMUNE TOLERANCE; MALE; MODELS, ANIMAL; PLATELET TRANSFUSION; PROTEOMICS; ULTRAVIOLET RAYS;

EID: 84869238626     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03583.x     Document Type: Article

References (47)

1. Webert KE, Cserti CM, Hannon J, Lin Y, Pavenski K, Pendergrast JM, Blajchman MA,. Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies. Transfus Med Rev 2008; 22: 1-34.
2. Mohr H, Gravemann U, Bayer A, Muller TH,. Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light. Transfusion 2009; 49: 1956-63.
3. Mohr H, Redecker-Klein A,. Inactivation of pathogens in platelet concentrates by using a two-step procedure. Vox Sang 2003; 84: 96-104.
4. Mohr H, Steil L, Gravemann U, Thiele T, Hammer E, Greinacher A, Muller TH, Volker U,. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion 2009; 49: 2612-24.
5. Cadet J, Sage E, Douki T,. Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res 2005; 571: 3-17.
6. Sinha RP, Hader DP,. UV-induced DNA damage and repair: a review. Photochem Photobiol Sci 2002; 1: 225-36.
7. Schmidt S, Kauling J,. Process and laboratory scale UV inactivation of viruses and bacteria using an innovative coiled tube reactor. Chem Eng Technol 2007; 30: 945-50.
8. Sandgren P, Tolksdorf F, Struff WG, Gulliksson H,. In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method. Vox Sang 2011; 101: 35-43.
9. Mohr H, Gravemann U, Muller TH,. Inactivation of pathogens in single units of therapeutic fresh plasma by irradiation with ultraviolet light. Transfusion 2009; 49: 2144-51.
10. Apelseth TO, Bruserud O, Wentzel-Larsen T, Bakken AM, Bjorsvik S, Hervig T,. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion 2007; 47: 653-65.
11. AuBuchon JP, Herschel L, Roger J, Taylor H, Whitley P, Li J, Edrich R, Goodrich RP,. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2005; 45: 1335-41.
12. Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP,. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004; 44: 877-85.
13. van Rhenen DJ, Vermeij J, Mayaudon V, Hind C, Lin L, Corash L,. Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats. Vox Sang 2000; 79: 206-14.
14. Vassallo RR, Adamson JW, Gottschall JL, Snyder EL, Lee W, Houghton J, Elfath MD,. In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma. Transfusion 2010; 50: 2376-85.
15. Chan HL, Gaffney PR, Waterfield MD, Anderle H, Peter Matthiessen H, Schwarz HP, Turecek PL, Timms JF,. Proteomic analysis of UVC irradiation-induced damage of plasma proteins: serum amyloid P component as a major target of photolysis. FEBS Lett 2006; 580: 3229-36.
16. Davies MJ,. Reactive species formed on proteins exposed to singlet oxygen. Photochem Photobiol Sci 2004; 3: 17-25.
17. Weingarten P, Lutter P, Wattenberg A, Blueggel M, Bailey S, Klose J, Meyer HE, Huels C,. Application of proteomics and protein analysis for biomarker and target finding for immunotherapy. Methods Mol Med 2005; 109: 155-74.
18. Heukeshoven J, Dernick R,. Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels. Electrophoresis 1988; 9: 28-32.
19. Laemmli UK,. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
20. Santos PM, Roma V, Benndorf D, von Bergen M, Harms H, Sa-Correia I,. Mechanistic insights into the global response to phenol in the phenol-biodegrading strain Pseudomonas sp. M1 revealed by quantitative proteomics. OMICS 2007; 11: 233-51.
21. Mann B, Madera M, Sheng Q, Tang H, Mechref Y, Novotny MV,. ProteinQuant Suite: a bundle of automated software tools for label-free quantitative proteomics. Rapid Commun Mass Spectrom 2008; 22: 3823-34.
22. Jehmlich N, Schmidt F, von Bergen M, Richnow HH, Vogt C,. Protein-based stable isotope probing (Protein-SIP) reveals active species within anoxic mixed cultures. ISME J 2008; 2: 1122-33.
23. Swanson MS, Nakagawa TY, LeVan K, Dreyfuss G,. Primary structure of human nuclear ribonucleoprotein particle C proteins: conservation of sequence and domain structures in heterogeneous nuclear RNA, mRNA, and pre-rRNA-binding proteins. Mol Cell Biol 1987; 7: 1731-9.
24. Ronimus RS, Morgan HW,. Distribution and phylogenies of enzymes of the Embden-Meyerhof-Parnas pathway from archaea and hyperthermophilic bacteria support a gluconeogenic origin of metabolism. Archaea 2003; 1: 199-221.
25. McAllister G, Whiting P, Hammond EA, Knowles MR, Atack JR, Bailey FJ, Maigetter R, Ragan CI,. cDNA cloning of human and rat brain myo-inositol monophosphatase. Expression and characterization of the human recombinant enzyme. Biochem J 1992; 284 (Pt 3): 749-54.
26. Cutler ML, Bassin RH, Zanoni L, Talbot N,. Isolation of rsp-1, a novel cDNA capable of suppressing v-Ras transformation. Mol Cell Biol 1992; 12: 3750-6.
27. Odabaei G, Chatterjee D, Jazirehi AR, Goodglick L, Yeung K, Bonavida B,. Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv Cancer Res 2004; 91: 169-200.
28. Zeng L, Imamoto A, Rosner MR,. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin Ther Targets 2008; 12: 1275-87.
29. Apelseth TO, Hervig TA, Wentzel-Larsen T, Bruserud O,. Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage. Transfusion 2006; 46: 800-10.
30. Cognasse F, Boussoulade F, Chavarin P, Acquart S, Fabrigli P, Lamy B, Garraud O,. Release of potential immunomodulatory factors during platelet storage. Transfusion 2006; 46: 1184-9.
31. Castrillo A, Costoya S, Arcas C, Tolksdorf F, Rodriguez MI,. The influence of pathogen inactivation treatment on platelet activation and cytokine levels. Vox Sang 2010; 99 (Suppl 1): 250.
32. Thiele T, Steil L, Gebhard S, Scharf C, Hammer E, Brigulla M, Lubenow N, Clemetson KJ, Volker U, Greinacher A,. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007; 47: 1221-33.
33. Unlu M, Morgan ME, Minden JS,. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997; 18: 2071-7.
34. Molloy MP, Brzezinski EE, Hang J, McDowell MT, VanBogelen RA,. Overcoming technical variation and biological variation in quantitative proteomics. Proteomics 2003; 3: 1912-9.
35. Kerwin BA, Remmele RL Jr., Protect from light: photodegradation and protein biologics. J Pharm Sci 2007; 96: 1468-79.
36. Wu CC, Wu SY, Liao CY, Teng CM, Wu YC, Kuo SC,. The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation. Br J Pharmacol 2010; 161: 643-58.
37. Schwarz T,. UV light affects cell membrane and cytoplasmic targets. J Photochem Photobiol B 1998; 44: 91-6.
38. Tyrrell RM,. UV activation of mammalian stress proteins. EXS 1996; 77: 255-71.
39. Sachsenmaier C, Radler-Pohl A, Muller A, Herrlich P, Rahmsdorf HJ,. Damage to DNA by UV light and activation of transcription factors. Biochem Pharmacol 1994; 47: 129-36.
40. Verhaar R, Dekkers DW, De Cuyper IM, Ginsberg MH, de Korte D, Verhoeven AJ,. UV-C irradiation disrupts platelet surface disulfide bonds and activates the platelet integrin alphaIIbbeta3. Blood 2008; 112: 4935-9.
41. Seltsam A, Mueller TH,. UVC irradiation for pathogen reduction of platelet concentrates and plasma. Transfus Med Hemother 2011; 38: 43-54.
42. Slichter SJ, Fish D, Abrams VK, Gaur L, Nelson K, Bolgiano D,. Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion model. Blood 2005; 105: 847-54.
43. Reid DM, Jones CE, Luo CY, Shulman NR,. Immunoglobulins from normal sera bind platelet vinculin and talin and their proteolytic fragments. Blood 1993; 81: 745-51.
44. Garratty G,. Autoantibodies induced by blood transfusion. Transfusion 2004; 44: 5-9.
45. Zavizion B, Purmal A, Chapman J, Alford B,. Inactivation of mycoplasma species in blood by INACTINE PEN110 process. Transfusion 2004; 44: 286-93.
46. Benjamin RJ, McCullough J, Mintz PD, Snyder E, Spotnitz WD, Rizzo RJ, Wages D, Lin JS, Wood L, Corash L, Conlan MG,. Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients. Transfusion 2005; 45: 1739-49.
47. North AK, Henschler R, Geisen C, Garratty G, Arndt PA, Kattamis A, Cohen A, Piga A, Arslan O, Galanello R,. Evaluation of naturally occurring antibodies to pathogen inactivated red blood cells. Transfusion 2010; 50 (Suppl): 38A.